# OptimizeRx Corp: Form 8-K, filed Apr 2, 2024

- Company: [OptimizeRx Corp](/companies/oprx.md) (CIK 1448431)
- Form: 8-K
- Filed: 2024-04-02
- Accepted by EDGAR: Apr 2, 2024, 20:05 ET
- Period: 2024-03-28
- Accession: 0001213900-24-029318
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1448431/000121390024029318/ea0203141-8k_optimize.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1448431/000121390024029318/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1448431/000121390024029318/ea0203141-8k_optimize.htm

Filed Apr 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-029318. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.